Malkhey Verma

983 total citations
43 papers, 700 citations indexed

About

Malkhey Verma is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Malkhey Verma has authored 43 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Hematology and 8 papers in Organic Chemistry. Recurrent topics in Malkhey Verma's work include Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Aldose Reductase and Taurine (7 papers). Malkhey Verma is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Aldose Reductase and Taurine (7 papers). Malkhey Verma collaborates with scholars based in India, United Kingdom and United States. Malkhey Verma's co-authors include Priyanka Singh, Villayat Ali, Sonu Gupta, K. V. Venkatesh, Paike Jayadeva Bhat, Hans V. Westerhoff, Sapna Thakur, Ganesaratnam K. Balendiran, Sonu Kumar Gupta and Vinod Kumar and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Malkhey Verma

40 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malkhey Verma India 15 430 108 99 70 54 43 700
Changshan Yang China 13 362 0.8× 68 0.6× 164 1.7× 42 0.6× 54 1.0× 14 546
Jo L. Bramhall United Kingdom 5 390 0.9× 44 0.4× 204 2.1× 41 0.6× 95 1.8× 9 760
Marina Vita Sweden 13 483 1.1× 90 0.8× 233 2.4× 46 0.7× 107 2.0× 17 879
Manuela Gridling Austria 13 672 1.6× 61 0.6× 269 2.7× 47 0.7× 97 1.8× 17 1.0k
Baobing Zhao China 18 485 1.1× 54 0.5× 85 0.9× 123 1.8× 105 1.9× 55 880
Ronald J. Rothman United States 10 862 2.0× 70 0.6× 135 1.4× 59 0.8× 87 1.6× 12 1.2k
Markus Dagnell Sweden 16 711 1.7× 38 0.4× 120 1.2× 43 0.6× 97 1.8× 23 1.0k
Wolfgang A. Schmalix Germany 20 464 1.1× 52 0.5× 172 1.7× 66 0.9× 275 5.1× 35 1.0k
Eli Oldham United States 2 452 1.1× 28 0.3× 119 1.2× 35 0.5× 133 2.5× 7 757

Countries citing papers authored by Malkhey Verma

Since Specialization
Citations

This map shows the geographic impact of Malkhey Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malkhey Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malkhey Verma more than expected).

Fields of papers citing papers by Malkhey Verma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malkhey Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malkhey Verma. The network helps show where Malkhey Verma may publish in the future.

Co-authorship network of co-authors of Malkhey Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Malkhey Verma. A scholar is included among the top collaborators of Malkhey Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malkhey Verma. Malkhey Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Singh, Vinay K., et al.. (2025). Molecular docking and dynamics simulation analyses of ibuprofen derivatives as potential anti-cancer agents targeting COX-2. SHILAP Revista de lepidopterología. 1. 100100–100100.
3.
Verma, Malkhey, et al.. (2024). Notes on AEMS methods development for high throughput experimentation in drug discovery. SLAS TECHNOLOGY. 29(6). 100234–100234. 1 indexed citations
4.
Itkin, Zina, Malkhey Verma, John Janiszewski, et al.. (2024). High-resolution acoustic ejection mass spectrometry for high-throughput library screening. SLAS TECHNOLOGY. 29(6). 100199–100199. 4 indexed citations
5.
Verma, Malkhey, et al.. (2024). Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels. Medical Oncology. 41(2). 55–55. 1 indexed citations
6.
Singh, Priyanka, et al.. (2022). Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review. Molecular and Cellular Biochemistry. 477(4). 1261–1279. 22 indexed citations
7.
Singh, Priyanka, et al.. (2022). Alterations in cellular metabolisms after Imatinib therapy: a review. Medical Oncology. 39(7). 95–95. 7 indexed citations
8.
Singh, Priyanka, et al.. (2021). Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review. Medical Oncology. 38(1). 10–10. 43 indexed citations
9.
Gupta, Sonu, Priyanka Singh, Ravindresh Chhabra, & Malkhey Verma. (2021). Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line. Leukemia Research. 109. 106641–106641. 4 indexed citations
10.
Thakur, Sapna, et al.. (2021). Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. Archives of Pharmacal Research. 44(7). 655–667. 101 indexed citations
11.
Verma, Malkhey, et al.. (2013). Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies. Integrative Biology. 5(3). 543–543. 15 indexed citations
12.
Verma, Malkhey, Maksim Zakhartsev, Matthias Reuß, & Hans V. Westerhoff. (2012). ‘Domino’ systems biology and the ‘A’ of ATP. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1827(1). 19–29. 4 indexed citations
13.
Nardelli, Maria, et al.. (2011). Absorption Spectroscopy. Methods in enzymology on CD-ROM/Methods in enzymology. 500. 59–75. 17 indexed citations
14.
Balendiran, Ganesaratnam K., M.R. Sawaya, Frederick P. Schwarz, et al.. (2010). The Role of Cys-298 in Aldose Reductase Function. Journal of Biological Chemistry. 286(8). 6336–6344. 18 indexed citations
15.
Westerhoff, Hans V., Catherine Winder, Hanan L. Messiha, et al.. (2009). Systems Biology: The elements and principles of Life. FEBS Letters. 583(24). 3882–3890. 67 indexed citations
16.
Verma, Malkhey, et al.. (2008). Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers. European Journal of Pharmacology. 584(2-3). 213–221. 32 indexed citations
17.
Balendiran, Ganesaratnam K., et al.. (2007). Chemistory of Fibrates. Current Chemical Biology. 1(3). 311–316. 10 indexed citations
18.
Verma, Malkhey, et al.. (2005). Biological significance of autoregulation through steady state analysis of genetic networks. Biosystems. 84(1). 39–48. 15 indexed citations
19.
Verma, Malkhey, Paike Jayadeva Bhat, Sharad Bhartiya, & K. V. Venkatesh. (2004). A steady‐state modeling approach to validate an in vivo mechanism of the GAL regulatory network in Saccharomyces cerevisiae. European Journal of Biochemistry. 271(20). 4064–4074. 11 indexed citations
20.
Verma, Malkhey, et al.. (1987). Potent anti-inflammatory 2-(o-hydroxyphenyl)-5-(p-dimethylamino phenyl)-1,3,4-oxadiazoles. Indian Journal of Pharmaceutical Sciences. 49(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026